Dermavant Sciences

Website:dermavant.com
Location:Phoenix, AZ United States
Revenue:N/A
Industry:Biotech
Founded:2016
Lead Investor(s):NovaQuest Capital Management
Press

Current Growjo Ranking

Industry Ranking

State Ranking

Growjo 10k Ranking

A Passion for Science and a Commitment to Dermatology Dermavant Sciences is a specialty biopharmaceutical company developing innovative prescription therapies for dermatologic diseases. Dermavant has acquired promising compounds that address unmet therapeutic needs and has rapidly established a robust dermatology R&D pipeline. We are dedicated to realizing the full potential of biomedical research and to developing and commercializing novel first-in-class or best-in-class therapies that improve patients lives. The patient is at the heart of everything we do.

keywords:N/A

47

Number of Employees

N/A

Revenue (est)

2

Current Jobs

124%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Dermavant Sciences News

21-Feb-19 - Dermavant Sciences to Present Data on Tapinarof for Psoriasis and

Dermavant Sciences to Present Data on Tapinarof for Psoriasis and Atopic Dermatitis at the 2019 American Academy of Dermatology Annual

20-Mar-19 - Vitiligo Drugs Market Around Globe: Growth, Development, Trends

... drugs market include, AXIM Biotechnologies, Dr. Reddy's Laboratories, Boston Pharmaceutical, Castle Creek Pharma, Dermavant Sciences,

1 hour ago - Comparison of Portola Pharmaceuticals Inc. (PTLA) and Genprex Inc

... Inc.; Daiichi Sankyo, Inc.; and Dermavant Sciences GmbH. The company was founded in 2003 and is headquartered in South San Francisco,

Dermavant Sciences Funding

DateAmountRoundLead InvestorsReference
2018-08-29$100.0MUndisclosedNovaQuest Capital ManagementArticle

Dermavant Sciences Executive Hires

DateNameTitleReference
2017-10-02Vince IppolitoPresident/cooArticle
2018-04-04David RubensteinChief Scientific OfficerArticle
2018-09-05Frank TortiExecutive ChairArticle
2018-11-16Todd ZavodnickCEOArticle
2019-01-03Philip BrownChief Medical OfficerArticle
2019-03-28Cyril AlloucheChief Financial Officer (Chief Financial Officer)Article